Ocular Response Analyzer: What It Is & How It Works

The Ocular Response Analyzer provides a deeper insight into eye health by assessing the cornea’s unique biomechanical properties and structural integrity.

The Ocular Response Analyzer, usually called the ORA, is a non-invasive eye instrument that measures how your cornea responds to a brief puff of air. Unlike a standard eye-pressure check, it captures something extra: the mechanical behavior of the cornea itself, specifically how it absorbs and bounces back from that puff. The device uses this information to produce a pressure reading that accounts for differences in corneal stiffness from person to person, and it generates two biomechanical metrics that have become increasingly important in diagnosing and managing conditions like glaucoma and keratoconus.

How the Air Puff Actually Works

During a measurement, the ORA sends a precisely calibrated jet of air at your cornea. The air pressure ramps up rapidly, pushing the cornea inward until it flattens for the first time. An infrared detection system registers this first flattening moment and records the air pressure at that instant. But the device doesn’t stop there. The air pressure continues to rise briefly, then falls. As the pressure drops, the cornea springs back outward, passing through a second flat state on its way to its original curved shape. The infrared system captures this second flattening too, along with its corresponding pressure.

These two pressure readings are not the same. The cornea resists the inward push slightly differently than it rebounds outward, because the tissue has viscoelastic properties: it partly behaves like a spring and partly like a shock absorber. The gap between those two pressure readings is where the device gets its most distinctive measurement. The whole process takes a fraction of a second, and you experience it much like the familiar “puff test” at a routine eye exam, though the ORA extracts far more information from that single puff.

The Four Numbers the ORA Reports

Every measurement produces four main outputs. Two relate to eye pressure and two describe the cornea’s mechanical character.

  • Goldmann-correlated IOP (IOPg): This is the ORA’s estimate of your intraocular pressure in a way that corresponds to the traditional gold-standard method, Goldmann applanation tonometry. It uses the average of the two air-pressure readings at flattening.
  • Corneal-compensated IOP (IOPcc): This is the pressure estimate that adjusts for the mechanical properties of your particular cornea. The idea is to reduce the influence of a thick, stiff cornea inflating the reading or a thin, flexible cornea deflating it.
  • Corneal hysteresis (CH): The difference between those two flattening pressures. It reflects the cornea’s ability to absorb and dissipate energy, essentially its damping capacity.
  • Corneal resistance factor (CRF): A related but distinct metric weighted more toward the cornea’s overall elastic resistance. It correlates more closely with corneal thickness than CH does.

Corneal hysteresis is the parameter that has generated the most clinical interest. It is a measure of the viscoelastic damping of the cornea, capturing something that corneal thickness alone cannot tell you. Two people can have identical corneal thickness but very different hysteresis values, and that difference turns out to matter clinically.

Why Corneal Hysteresis Matters for Glaucoma

Glaucoma management has traditionally focused on eye pressure and visual field testing. Corneal hysteresis adds a third dimension. In a prospective study of glaucoma patients, each 1 mmHg lower CH was associated with a faster rate of visual field decline over time. That relationship held even after accounting for other known risk factors. Separate research found that lower hysteresis, but not corneal thickness, was linked to visual field progression in glaucoma patients.

This distinction matters because for years, ophthalmologists focused on central corneal thickness as the key corneal factor in glaucoma risk, largely because the Ocular Hypertension Treatment Study found it to be a strong predictor. But hysteresis captures something different. A cornea can be thick yet poorly damped, or thin yet resilient. The ORA lets clinicians separate those two qualities rather than lumping them together. As a practical consequence, some glaucoma specialists now use CH as one more data point when deciding how aggressively to treat a patient whose pressure is borderline.

The ORA has also revealed differences between subtypes of open-angle glaucoma. Patients with high-pressure glaucoma showed a higher corneal resistance factor compared to those with normal-pressure glaucoma in ORA testing. Findings like these are nudging the field toward recognizing that the cornea’s mechanical behavior is intertwined with how glaucoma develops and progresses, not just with how accurately we measure pressure.

Screening for Keratoconus and Corneal Weakness

Before refractive surgery like LASIK, surgeons need to identify corneas that are at risk of bulging outward afterward, a condition called ectasia. Keratoconus, where the cornea progressively thins and cones forward, is the classic red flag. ORA measurements can help here because keratoconic corneas tend to have distinctly lower CH and CRF values than healthy ones. One study found that CRF was better than CH at detecting keratoconic corneas once the confounding effect of corneal thickness was accounted for, even in the topographically normal-looking fellow eyes of keratoconus patients.

That said, the ORA has limits in this area. Research comparing healthy eyes, keratoconus-suspect eyes, and confirmed keratoconus eyes found that while CH and CRF could distinguish frank keratoconus from normal eyes, they were less reliable at identifying the earliest suspect cases, which is precisely where screening matters most. For that reason, the ORA is typically used alongside corneal topography and tomography, not as a standalone screener. It adds a mechanical perspective to what is primarily a shape-based assessment.

What Refractive Surgery Does to ORA Readings

LASIK and similar procedures permanently remove corneal tissue, so it is no surprise that they change the cornea’s biomechanical behavior. After LASIK, both CH and CRF drop significantly. The same pattern appears with SMILE, the newer flapless laser procedure, though the two techniques may differ in the magnitude of change.

This matters for a very practical reason: if you had LASIK years ago and now go in for a routine eye exam, your pressure reading from a standard tonometer will often be falsely low, because the thinner, less stiff post-surgical cornea makes it too easy for the instrument to flatten. A meta-analysis pooling data from studies that compared ORA and Goldmann tonometry after refractive surgery found that the corneal-compensated IOP from the ORA ran about 2.7 mmHg higher than the Goldmann reading after surgery. In other words, the ORA’s corneal-compensated reading tracked true pressure more faithfully after the cornea had been surgically altered. Meanwhile, the Goldmann-correlated IOP from the ORA dropped more steeply than either the standard Goldmann reading or the corneal-compensated reading, reflecting how strongly the traditional measurement method is influenced by the cornea it has to push through.

A study specifically looking at LASIK found that the ORA’s corneal-compensated IOP dropped less than the Goldmann-correlated IOP after surgery, consistent with the idea that IOPcc partially corrects for the structural change. For anyone with a history of refractive surgery, this makes the ORA particularly useful in long-term monitoring, especially if glaucoma screening is a concern later in life.

How It Compares to Traditional Tonometry

The Goldmann applanation tonometer remains the clinical reference standard for measuring eye pressure, but it has well-known blind spots. It assumes a “normal” cornea, and deviations in thickness or stiffness can nudge its readings up or down. The ORA was built partly to address this limitation, but its readings and Goldmann readings do not always agree. In one study of healthy subjects, both the Goldmann-correlated and corneal-compensated ORA pressures ran consistently higher than Goldmann, and the discrepancy grew larger at higher pressures.

Repeatability is another consideration. One head-to-head comparison of different tonometers found that the ORA’s corneal-compensated IOP had more measurement variability between sessions than either Goldmann or dynamic contour tonometry. This does not mean IOPcc is inaccurate, but it does mean that clinicians sometimes need to take multiple readings and average them, or focus on the highest-quality measurement, to get reliable numbers. In children, the comparison is similarly imperfect: ORA, Corvis ST, and Goldmann readings in healthy pediatric eyes showed only weak to modest correlations with one another.

After a corneal transplant, the situation is even more complex. ORA-derived corneal-compensated IOP and Tono-Pen readings were both higher than Goldmann in post-transplant eyes, and corneal thickness did not correlate with any tonometry method, reinforcing the idea that in altered corneas, no single pressure tool tells the complete story. The ORA’s advantage in these scenarios is not necessarily a more “correct” single number, but the additional biomechanical data that help the clinician interpret whatever number they get.

Waveform Scores and Measurement Quality

Beyond the four headline numbers, the ORA generates a detailed signal waveform from each measurement, essentially a graph showing how the infrared detection signal changes as the cornea deforms and rebounds. The manufacturer has developed a set of waveform-derived parameters that analyze the shape, height, width, and symmetry of the two peaks in this signal. From these, a single Waveform Score is computed that rates the quality of each individual measurement.

This quality score matters more than many users realize. A well-aligned measurement produces tall, narrow, symmetrical peaks. A poor one, caused by the patient blinking, the eye not being centered, or the air puff hitting at an off angle, produces a messy waveform and an unreliable CH or CRF value. Research protocols typically require a Waveform Score of at least 6 out of 10, and some set the bar higher.

A recent study in keratoconus patients and controls found that analyzing the single highest-quality measurement from a series produced better-differentiated results than simply averaging all measurements together, because the best reading had taller and narrower waveform peaks, suggesting better device-to-eye alignment. If you are having ORA testing done, do not be surprised if the technician takes several readings and selects the best-scoring one rather than averaging the batch.

Age, Diabetes, and Other Factors That Shift Readings

Your ORA values are not fixed for life. Both CH and CRF decline with age. A study examining age-related changes found a significant negative relationship between age and both metrics. Separate 24-hour monitoring confirmed that older adults had consistently lower CH and CRF than younger adults around the clock, and this was independent of corneal thickness. The cornea stiffens and loses its damping capacity over time, much like other tissues in the body.

Diabetes pushes readings the other way. In diabetic patients, both CH and CRF were elevated compared to healthy controls. This likely reflects the cross-linking effect that chronic high blood sugar has on collagen throughout the body. The cornea becomes stiffer and more resistant, which could make standard pressure readings run high and mask true intraocular pressure in some cases. Clinicians managing diabetic patients need to keep this in mind when interpreting any tonometry result, ORA-derived or otherwise.

Time of day also plays a role. A study of both glaucoma patients and healthy volunteers found that CH was higher at night than during the day, while IOP showed the opposite pattern. The magnitude of this swing was similar in glaucoma and non-glaucoma eyes, suggesting it reflects a fundamental property of the cornea rather than a disease effect. For research purposes, this means the timing of measurements matters. For a single clinical visit, the practical impact is small, but knowing these fluctuations exist helps explain why a patient’s CH might differ slightly from one appointment to the next.

Tracking Treatment Effects

The ORA has been studied as a way to measure whether treatments that are supposed to strengthen the cornea actually do so. Corneal collagen cross-linking, a procedure used to halt keratoconus progression, is the most obvious candidate. One randomized controlled trial, however, found no significant change in CH or CRF one year after cross-linking compared to preoperative values. An independent study using a different measurement technology did detect an increase in hysteresis at one and six months after cross-linking, but the ORA itself did not pick up the same change.

This apparent insensitivity is a genuine limitation. Cross-linking is known to stiffen the anterior corneal stroma, but the ORA’s air-puff approach may not be refined enough to detect the relatively localized mechanical change. It is possible that the stiffening occurs in a layer the puff interacts with only partially, or that the effect is too small relative to the ORA’s measurement variability. Whatever the explanation, clinicians generally do not rely on ORA readings alone to judge whether cross-linking has worked; they use corneal topography and visual outcomes instead.

On the pharmacological side, the picture is more encouraging. Treatment with latanoprost, a prostaglandin analogue commonly used to lower eye pressure in glaucoma, produced a measurable increase in CH that was independent of the drug’s pressure-lowering effect. This is an intriguing finding because it suggests that some glaucoma drugs might influence the cornea’s mechanical properties directly, not just by reducing the pressure inside the eye. Whether this corneal effect contributes to the drug’s protective benefit, or is just a side observation, is still an open question.

The ORA Versus the Corvis ST

The ORA is not the only device measuring corneal biomechanics. The Corvis ST, made by a different manufacturer, also uses an air puff but adds a high-speed Scheimpflug camera that records the cornea’s deformation in cross-section. This means the Corvis captures visual data about how deeply the cornea indents and how quickly it recovers, while the ORA relies entirely on its infrared applanation signal.

Comparing the two devices’ spectral waveform data showed statistically significant differences in several parameters, meaning their outputs are not interchangeable. Each device excels in slightly different contexts. The ORA’s strength is the large body of longitudinal glaucoma data linked to CH as a risk factor, giving it a clinical track record that the Corvis is still building. The Corvis, on the other hand, provides more detailed deformation imaging and has its own set of parameters increasingly used in ectasia screening. Many academic cornea and glaucoma practices now have both, treating them as complementary rather than redundant tools.

For patients, the practical experience with either device is almost identical: you sit with your chin on a rest, stare at a target, and feel a quick puff of air. Neither touches the eye, and neither requires anesthetic drops. The ORA measurement typically takes under a minute once you are positioned, though the technician may run it several times to ensure a high-quality waveform.